Preliminary therapetic treatment of ￣（90）Y-EDTMP for the bone metastatic pain

您当前的位置：

首页 >

文章列表页 >

Preliminary therapetic treatment of ￣（90）Y-EDTMP for the bone metastatic pain

更新时间：2021-04-09

- Preliminary therapetic treatment of ￣（90）Y-EDTMP for the bone metastatic pain
- NUCLEAR TECHNIQUES Issue 5, (1995)
- 作者机构：
  
  中山医科大学孙逸仙纪念医院
- 作者简介：
- 基金信息：
- DOI：
  CLC： R454.2
- Published：01 May 1995
- 稿件说明：
移动端阅览
[1]蒋宁一,吕斌,卢献平,梁九根,刘生.~（90）Y—EDTMP治疗骨转移疼痛的初步应用[J].核技术,1995(05):290-292.

Preliminary therapetic treatment of ￣（90）Y-EDTMP for the bone metastatic pain[J]. Nuclear techniques, 1995, (5).
[1]蒋宁一,吕斌,卢献平,梁九根,刘生.~（90）Y—EDTMP治疗骨转移疼痛的初步应用[J].核技术,1995(05):290-292. DOI：

Preliminary therapetic treatment of ￣（90）Y-EDTMP for the bone metastatic pain[J]. Nuclear techniques, 1995, (5). DOI：

摘要

采用９０Ｙ－ＥＤＴＭｐ治疗骨转移疼痛病人７２例（１５６人次）。５３例随访资料表明，止痛效果显著者１３例，有效者２８例，总有效率达７７．４％（４１／５３）。其中１７例病人外周血象一过性下降，７例发生用药后瞬间反应性疼痛加重。未发现不可逆骨髓抑制现象及肝功能受损。结果表明，９０Ｙ－ＥＤＴＭＰ治疗骨转移疼痛效果好，副作用少，使用方便，适合于各种恶性肿瘤骨转移患者。

Abstract

To relieve bony pain due to disseminated bone metastases

72 patients were treated with 90Y-EDTMP with dosage of 7.4-9.25 mBq/kg in 122 times.53 patients were followed

among them 13 had significant pain relief

28 effective

the overall effective ratio was 77.4%（41/53）.In 17 patients transcient decreasing of the peripheral blood cell occured

and 7 patients had reactive pain aggravation in short duration. No irreversible bone marrow depression and liver function injury was found. It was considered 90Y-EDTMP is an easy

less side effect and effective method for the relief of bone metastetic pain.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Preliminary experimental animal study on reducing ²²³Ra gastrointestinal radiation injury by EDTA complexation in vivo

Significance of BAP and PSA in diagnosis of prostate cancer bone metastases

The animal investigation on the treatment of prostate proliferation by³²P-GTMS and its preliminary study of clinical application

Preliminary results of therapeutic trial with ⁸⁹SrCl₂ in skeletal metastases

Preliminary clinical study of ⁸⁹Sr in palliation in painful skeletal metastases

Related Author

ZUO Changjing

PENG Ye

JIA Guorong

YANG Jian

LI Xiao

LI Danni

袁志斌

JI Hong YU Jianfang YUAN Zhibin ZHU Ruisen

Related Institution

Department of Nuclear Medicine, Shanghai Changhai Hospital

Shanghai Sixth People’s Hospital, Shanghai Jiaotong University

上海交通大学附属第六人民医院核医学科

Shanghai Huangpu District Central Hospital

上海市黄浦区中心医院

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：880780 Visits Today：307

⁰